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Abstract
Epstein-Barr virus (EBV) is the prototypical example for episomal persistence of genetic information.
Yet, little is known about how this viral episome is lost. Episome loss occurs naturally in naso-
pharyngeal carcinoma (NPC) upon explantation into culture. Using whole-genome profiling, we
found evidence for 2 different pathways of episome loss: (i) rapid loss of the entire episome or (ii)
successive mutation/deletion of the episome until at least 1 essential cis-element is destroyed. This
second phenotype was seen in a clone of HONE-1 NPC cells that maintains the EBV episome for
prolonged time in culture. The conceptual insights provided by our quantitative analysis should aid
our understanding of mammalian episomes, as well as lead to designs to cure latent viral infection.
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Epstein-Barr virus (EBV) is a human oncogenic virus, which has been associated with
infectious mononucleosis (IM),1 African Burkitt’s lymphoma (BL)2 and nasopharyngeal
carcinoma (NPC).3 In these cancers, the virus is maintained extrachromosomally as a circular
episome. The EBV latent origin of replication (ori-P), the EBV nuclear antigen 1 (EBNA-1)
coding region and the promoter are the only cis-elements required to maintain the latent
episome (or any artificial circular plasmid).4–6 Only the Qp promoter is used to maintain
EBNA-1 expression in NPC.7
In EBV-positive NPC, every tumor cell contains the viral episome. In contrast to lymphocyte
lineage tumors, it has been exceedingly difficult to establish permanent cell lines from NPC
tumors that maintain the EBV episome during continuous culture. Rare examples of such cell
lines include CNE-1 and CNE-2, which were derived from NPC patients in China (Cancer
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Institute, Beijing, 1978)8 and NPC/HK1 from a patient in Hong Kong.9 Even though these cell
lines were obtained from EBV genome positive NPC biopsies, none remained EBV genome
positive after prolonged culture. Upon experimental infection of epithelial cells in culture, the
EBV viral genome is rapidly lost, unless drug selection is applied.10 Other EBV-positive
epithelial-lineage primary tumor cells, such as HNE-1, also rapidly lose the virus upon
explantation into culture. This has severely hampered our understanding of EBV-associated
epithelial lineage tumors such as NPC and EBV-positive gastric carcinomas.
Our laboratory, in collaboration with Dr. Kaitai Yao and his group at the Hunan Medical
University (Hunan, People’s Republic of China) were able to establish an NPC-derived cell
line that contained the EBV genome in a stable manner with the cell genome.11 This cell line,
HONE-1 clone 40, was characterized in previous reports.11–13 As far as we know, this was the
first NPC cell line to contain a stable EBV genome for over 40 passages. Unfortunately, this
cell line is no longer available. Here, we used another clone that was isolated from the same
NPC biopsy, HONE-1 clone 13 cells. HONE-1 clone 13 cells were EBV DNA positive at early
passage, but the relationship between EBV DNA and the NPC tumor cells was unstable. This
resembles the prototypical response of EBV-infected epithelial cell tumors after explantation
into culture. We have taken advantage of this model to explore the fundamental mechanisms
of EBV episome loss.
Whole EBV genome profiling shows that in addition to losing the entire viral episome at once,
as previously observed,5 NPC cells can also lose the episome through accumulative mutations,
deletions and recombination. The rate of loss by this second, novel mechanism is slower. Since
HONE-1 clone 13 cells do not depend on EBV for growth in culture, defective genomes can
accumulate. This second, gradual mechanism of episomal loss may explain the variation found
in EBV episome maintenance in current NPC models.
Material and methods
Tissue culture
In this study, we used “uncloned”, parental HONE-1 cells and HONE-1 clone 13 cells. Both
cell lines were isolated from the same NPC biopsy as the HONE-1 clone 40 cells. Every effort
had been made to prepare all HONE-1 clones as quickly as possible as the parental HONE-1
cells were grown out from the NPC tumor specimen. All cultures were maintained at 37°C and
grown in RPMI 1640 medium supplemented with 10% fetal bovine serum (FBS) as described.
14
DNA extraction
Cells were trypsinized, pelleted at 1,700 rpm for 5 min in a tissue culture centrifuge, and washed
twice with calcium and magnesium-free phosphate-buffered saline. Total DNA from 1 × 106
cells was extracted by proteinase K digestion (at 1 mg/ml) in 100 μl hypotonic lysis buffer (10
mM Tris/HCl pH 8.0, 2.5 mM MgCl2, 1% IGEPAL, 1% Tween-20) for 30 min at 50°C in a
PCR tube. Subsequently, proteinase K was inactivated by incubation at 95°C for 15 min.
Lysates were divided into 10-μl aliquots and stored at −80°C until use.
Primer design
Primers were designed using the PrimeTime program,15 which is based on the European
Molecular Biology Open Software Suite (EMBOSS)16 and ePrimer317 using the EBV genome
as input sequence (nucleotide entry GI:23893576).
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Real-time QPCR for EBV latent membrane protein-1 (LMP-1), GAPDH and all other EBV
gene loci DNA was performed as described18,19 using SYBR Green as the method of detection.
Primer sequences are provided in Supplemental Table I. EBV nuclear antigen 1 (EBNA-1) and
the gene for the ribosomal 18S RNA were quantified using TaqMan™. Briefly, DNA was
diluted with distilled H2O to yield 250 μl, mixed with 500 μl 2× SYBR PCR mix (Applied
Biosystems), and aliquoted into individual wells (12.5 μl/well) of a 96-well PCR plate using
a CAS-1200 robot (Corbett). Individual EBV primers were used at 267 nM final concentration.
Real-time quantitative PCR was performed on an MJR Opticon2 cycler (see Ref. 20 for details).
The cycle-threshold values (CT) were determined by automated analysis. Lower CT values
correspond to higher gene copy number. The threshold was set to 5 times the standard deviation
(SD) of the nontemplate control (NTC).
Statistical analysis
Calculations were performed using Excel™ (Microsoft, Redwood, WA) and SPSS™ v11.0
(SPSS Science, Chicago, IL) under Macintosh OS v.10.4. Additional calculations were
performed in Maple™ v.10 (Waterloo Software). Hierarchical clustering was performed using
ArrayMiner™ software (Optimal Design, Brussels, Belgium) as previously described.21
Chromosome analysis, mitochondrial DNA analysis and EBER in situ hybridization
Exponentially growing HONE-1 parental and HONE-1 clone 13 cells were fixed using standard
laboratory procedures. Cell suspensions were prepared and dropped onto precleaned, warm,
wet slides. The slides were aged at 90° C for 1 hr, banded with trypsin and stained with Wright
stain. Banded metaphases were analyzed using a Zeiss Axioskop 40 microscope. For each cell
line meta-phases were karyogramed using an Applied Imaging Karyotyping System. The
metaphases were described using ISCN (2005).22
Using primers specific for the human mitochondrial region, which are validated for forensic
PCR,23 we PCR-amplified 2 regions from every passage of cells used in our experiments and
sequenced the resulting PCR products. Sequences were aligned using Sequencher v4.8 (Gene
Codes Corporation, Ann Arbor, MI).
For EBER-ISH, pellets were enmeshed in thrombin using a Cytoblock Kit and fixed in 10%
Formalin overnight followed by paraffin embedding and cutting of 5-μm thick sections. H&E
staining confirmed presence of cells. In situ hybridization was carried out on a Ventana
Benchmark instrument using an EBER probe (Ventana Medical System, probe
CAT#780-2842). Parallel hybridization with an oligodT probe (Control probe CAT#
780-2846) showed the extent to which RNA was preserved and available for hybridization. A
nasopharyngeal carcinoma biopsy section used as a control showed sensitive and specific
EBER staining. ISH results were evaluated for staining intensity (0–4+) and proportion (0–
100% of cells).
Mathematical model
Our data result from QPCR amplification with multiple primer pairs p1…n, n = 1, …, 75 each
located within an EBV orf. We have total DNA from several successive passages 0, 4, 8 and
22 indicated by tk, k = 1…4. To exclude variation due to DNA extraction efficiency and cell
number per flask, raw EBV CT values were normalized to a single host DNA-specific primer
to yield dCT = CTEBV primer; 1…75 − CTgapdh. Under the hypothesis of whole chromosome
loss, the differences between any 2 primers pairs ddCT = dCTi − dCTj remained constant for
different passages tk. They reflect the ratio of the relative primer efficiencies Keff. The ddCT
are normal distributed.
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To approximate recombination rates for circular episomes, Figure 5 tests the hypothesis that
any 2 adjacent orfs i and i + 1 are either retained or lost together. The more distant any 2 orfs
are from each other, such as orf i and orf i + 2, or orf i and orf i + 3, and so on, the more
recombination can be expected. One orf may be lost and the other retained during continuous
culture. This is calculated by comparing ddCTi,i+1 = dCT(pi) − dCT(pi+1) to ddCTi,i+2 = dCT
(pi) − dCT(i+2) for all primers at a given passage tk. Between passages t we expect a higher
correlation of i + 1 differences to each other than to i + 2 differences.
Results
EBV DNA is lost upon explantation of NPC tumor cells at different rates
In the absence of selection, EBV-infected epithelial cells lose the virus over time. This
represents a major technical limitation to experimental EBV virology, which has plagued the
establishment of EBV-positive adherent cell lines and slowed investigations into EBV-
associated epithelial cell cancers. Yet, it resembles the natural course of events after
explantation of EBV-positive tumor cells from EBV-associated epithelial cancers, such as
NPC, and provides a general model system to study large (≥100 kbp) episome loss from
mammalian cells.
Here, we employ the HONE-1 cell system to understand the mechanism of the loss of EBV
episomal DNA in NPC tumor cells. Previously, viral load was measured using a single probe
directed against a short segment of the episome by either DNA hybridization or PCR. These
studies showed that the EBV episome was lost upon the adaptation of primary NPC tumor cells
to growth in an artificial medium.24,25 The experimental design using only a single probe for
the viral genome could not determine whether the viral episome was being lost in 1 piece or
whether it was being lost through cumulative deletions. This could theoretically be
accomplished by successive subgenomic deletions first leading to defective genomes, which
are then lost only after an essential gene function becomes impaired. To decide between these
2 scenarios, we use a real-time QPCR-based EBV genome array that contains 1 primer pair
for each viral orf.
Cells from cultures of HONE-1 parental and HONE-1 clone 13 cells were completely
karyogramed. Supplemental Figures 1a and 1b show karyotypes of the 2 HONE-1 cell lines.
The 2 NPC cell lines were almost identical, near-tetraploid, with nearly all of the same structural
abnormalities, including the same marker chromosomes. The only difference between the
HONE-1 cell lines were the presence of 3 normal 16s in the parental cell line and 4 normal 16s
in HONE-1 clone 13 cells, in the parental cell line, which was not seen in HONE-1 clone 13
cells and a twelfth marker in HONE-1 clone 13 cells not seen in the parental cell line. Both
cell lines showed some cell-to-cell heterogeneity. Complete ISCN descriptions are shown in
Supplemental Table II.
To confirm prior reports on HONE-1 cells, we used samples previously prepared from cells
frozen at different passage levels. Our definition of a passage indicates the number of times
the cells were trypzinized and seeded into new flasks. We extracted DNA and conducted PCR
using primer pairs directed against 2 different EBV genes (LMP-1 and EBNA-1). To determine
whether the HONE-1 cells contained the EBV genome, we performed PCR with primers
specific for LMP-1. Primers directed against GAPDH were used as control for DNA
purification. In this and subsequent experiments only a single band was observed after PCR
analysis attesting to the specificity of all primers (Fig. 1a and data not shown). Two independent
cultures of parental HONE-1 cells at Passage 8 contained EBV DNA, whereas in 2 later
passages, 12 and 21, the amount of the EBV DNA was below the detection limit of the assay.
Based on EBER-ISH, 2% of cells were EBV positive at Passage 9 (data not shown). Of note,
even though late passage parental HONE-1 and HONE-1 clone 13 no longer contain the EBV
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genome or any pieces of it (see later), the cells continue to grow in culture indefinitely and also
are tumorigenic in nude mice (unpublished observation). This result corroborates the known
phenotype of EBV episome loss in NPC explants.
Using primers specific for the human mitochondrial region, which were validated for forensic
PCR, we amplified 2 regions of the mitochondrial genome from every passage of cells used in
our experiments, sequenced the resulting PCR products and looked for evidence of single
nucleotide sequence polymorphism (SNP) (Supplemental Table III). There were no SNPs in
Region 1. Region 2 showed 9 SNPs, which were the result of a double peek in 1 sample, namely
clone 13 Passage 2. All other sequences were identical. This demonstrates that all the cells
analyzed herein represent clonal populations that stemmed from the same donor.
Evidence for biphasic EBV episomal loss from primary NPC explant cultures
We improved upon prior studies by using real-time QPCR with primers directed against the
EBNA1 coding region. This determined the total rate of episome loss, since EBNA1 is required
for latent oriP-dependent replication and partitioning. Any cell that does not express EBNA-1
loses all EBV episomes, whereas even minimal EBV episomes are maintained as long as
EBNA-1 protein is present. Similar overall DNA amounts were used as input. This was
evidenced by measuring the amount of the cellular gene for 18S ribosomal RNA, which yielded
a mean CT18S of 19.81 with a SD of 1.92. The 95% confidence interval (95CI) was 18.96–
20.69 across n = 20 samples. CT values generated from real-time QPCR represent a logarithmic
measure of target copy number, wherein a lower CT value represents a higher level of target.
A SD of 1.92 corresponds to 21.94 = 3.7-fold. To adjust for variability in DNA input levels, we
normalized CT values for EBNA-1 (CTEBNA1) to host DNA as follows: dCT = CTEBNA1 −
CT18S (Figs. 1b and 1c). All reactions were conducted in duplicate. Technical replicates, which
reflect the overall pipetting and detection error, differed on average by 0.89 CT units (95CI:
0.00–1.77, n = 10) for CT18S. The reproducibility of duplicates was not affected by input DNA
levels. This can be shown by a lack of correlation between variability and mean levels.26 The
regression coefficient r2 of difference vs. mean was 0.0338, demonstrating that we operated
within the linear range of the assay. To obtain biological replicates, we determined the DNA
content for HONE-1 clone 13 cells at Passage 4 and immediately thereafter at Passage 5. This
yielded identical results for viral DNA levels (dCTpassage 4 = 16.12 and dCTpassage 5 = 16.67,
respectively, Fig. 1b) and attests to the reproducibility of our DNA extraction procedure.
We used cells of 2 different NPC cultures. HONE-1 clone 13 is a unique clonal derivative of
the original HONE-1 explant culture. It has been shown to retain the EBV genome in the
absence of selection at early passages and without rapid loss of the EBV genome for some
time.11,12 It shows a constant, slow rate of EBV genome loss (Fig. 1b), which correlates linearly
with passage number (r2 = 0.688 with slope of m = 0.38 ± 0.15, n = 5). By contrast, the uncloned
HONE-1 cell population, representing the parental explant population, showed a biphasic rate
of episomal loss (Fig. 1c): first, a typical, rapid phase of EBV episomal loss (as previously
observed27), followed by a “slow”, more gradual rate of loss, which correlates linearly with
passage number (r2 = 0.865 with a slope of m = 0.50 ± 0.20, n = 3). The rate of episome loss
in the latter phase of parental HONE-1 cells was not significantly different from the rate of
loss of HONE-1 clone13 cells. After Passage 21, the EBV DNA signal was below the limit of
detection in both cultures. The biphasic behavior of the uncloned HONE-1 population is typical
for primary NPC explant cultures and was our first indication of 2 pathways for EBV episome
loss: the first, rapid and almost catastrophic; the second, gradual and correlated with passage
number in culture.
We hypothesized that the 2 quantitative different phases of episome loss correspond to 2
qualitatively different mechanisms of episome loss and that catastrophic loss precedes gradual
degradation. The parental, uncloned cell population starts out with a higher average EBV copy
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number as reflected in a lower dCT18S at Passage 8. This is followed by rapid episome loss as
reflected in an increased dCT18S at later passages (Fig. 1c). At around Passage 10 both HONE-1
clone 13 and parental cell populations exhibit equivalent average copy numbers, and from that
point on changed at a similar rate.
These data support the idea of a finite carrying capacity for long-term episomal maintenance
in latently infected cells. Although clonal variation can result in initial high variability of
episome copy number (Passage < 10), once the cells become culture-adapted (Passage > 10)
both NPC cultures carry the same average EBV episome number and lose the episome at a
similar constant rate. We do not know the molecular mechanism behind this phenotype. One
could speculate, however, that a host factor, such as a replication licensing protein, becomes
rate limiting as the cells adapt from the tumor microenvironment to single cell growth in culture.
Different pathways can account for loss of episomes
We envision 2 scenarios, depicted in Figure 3, to explain the loss of EBV episomes: (i) the
entire episome is either propagated to the next generation or lost as a whole; (ii) intraepisomal
mutation, deletion and/or recombination takes place generating 2 partial episomes. Only the
part of the genome that contains all essential cis-elements is propagated to the next generation.
These scenarios are not mutually exclusive.
These scenarios lead to different genome configurations over time, which we measured by
quantifying the level of all different EBV genes (primer pairs p1 …n, n = 75), each located
within a different EBV orf in relation to each other. Each of these loci was quantified
independently using real-time QPCR at Passages 0, 4, 8, 22 after explantation from the tumor.
If the entire episome is lost as a whole (Figure 2a), then all orfs are lost at the same rate. At
each passage, each orf will be present at the same copy number within the culture. Alternatively,
if the episome shrinks by recombining out nonessential orfs (Fig. 2b), individual orfs will be
lost at different rates. At each passage a given orf may or may not be present at the same copy
number as all other orfs. The further any 2 orfs are apart from each other, the more likely a
recombination event can occur. If EBNA, oriP and Qp were in the same location, the chance
of losing a particular orf by recombination would increase linearly as its distance increases
from the oriP. In EBV, however, the 3 essential elements EBNA, oriP and Qp are located in
different places on the circular episome. Therefore, a linear distance relationship is not expected
(Fig. 2c). The recombination distance function for circular episomes with multiple essential
elements is not trivial and was approximated as described in the Material and methods section.
An important aspect of this model is that the pattern of orf loss relative to each other is not
affected if the episome replicates in between host cell divisions28 or if not. Traditionally, the
rate of single gene loss is calculated by normalizing the levels for each single orf (as measured
by a real-time QPCR primer pair pi) at each passage to cellular DNA (18S RNA gene locus)
dCT(pi) = CT(pi) − CT18s and plotting dCT(pi) against passage number as in Figure 1. This
assumed rate of loss to be constant. In contrast, in our novel array approach, we normalize CT
for each primer pi at each passage tk to the median of all 75 primers for that sample dCT(pi) =
CT(pi) − CT(pmedian). This yields the relative copy number of 1 orf to all others. If an orf is
recombined out or lost by deletion, its relative copy number will decrease. This is reflected by
an increased dCT(pi) value, as more cycles are needed to detect residual cells within the flask
that still carry an intact episome. Importantly, this normalization method neither requires that
the rate of viral episome loss be constant nor that all primers have equivalent efficiency.15,29
Our model further assumes that any fragment that is separated from the oriP is irretrievably
lost, and that any time a recombination/cell division event separates EBNA-1, oriP and Qp, all
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viral genome fragments are lost during subsequent cell division, i.e., there is only 1 latent origin
per genome.
Of note, at each passage only a fraction of cells is transferred to the next flask, such as only
10% in a “1:10 split”. This explains why pieces of EBV, which are not able to replicate in
between passages, become diluted out with increasing passage number. The only exception
here would be pieces that were integrated into the host chromosome genome. Since both NPC
cultures lost all EBV genes at the last passage, we conclude that this was not the case.
A real-time QPCR array for EBV allows comparative gene copy number determination
We used our real-time QPCR-based microarray for EBV18,19 to experimentally distinguish
between the 2 possible scenarios. Figure 3 shows the distribution of primers across the EBV
genome. The actual primers used in the array (gray diamonds) show 100% sequence identity.
Therefore, the number of matches is equal to the total primer length. Using blastN we also
computed the next best match for each primer on the EBV genome, which could result in
missprimed amplification products. The next best match for each primer on the EBV genome
is shown in open circles. There are at least seven [95CI: 7.82, …, 8.53 (n = 160)] nucleotide
mismatches between the correct match (gray diamonds) and the next best match (open circles)
making it unlikely that under our QPCR conditions (Tm = 62°, extension time 60 sec) a given
primer would anneal anywhere else but at its cognate site. Exceptions were the BWRF1
primers, which can anneal at multiple locations in the BWRF1 repeats. Except for the internal
repeat (IR) region, our array covers the entire genome evenly. The mean distance between
adjacent primers was 1714 bp (95CI: 1394, …, 2033 bp for n = 75 primers pairs). Hence, this
array has a resolution of ~2,000 bp.
We used this genome array to determine EBV genome copy number (Fig. 4). All HONE-1
clone 13 cell time points (Passages 2, 4, 5, 10, 19) were measured in biological duplicates,
HONE-1 parental cells at time point Passage 8 were measured in biological duplicate, and
Passages 12 and 21 represent single measurements. All measurements were normalized to total
DNA using primers specific for GAPDH. Figure 4 plots dCTgapdh for each EBV orf in HONE-1
clone 13 cells at successive passages5,10,19 on the vertical axis relative to dCTgapdh for each
EBV orf at Passage 2 on the horizontal axis.
With increasing passage number most EBV-derived signals were lost, as evidenced by an
increase in dCT. Because 40 was the maximal cycle number in our QPCR protocol, the
maximum value of dCT was 40-CTgapdh, which is ~8 units. At Passage 5 (Fig. 4a), we were
able to detect almost all orfs. Except for a few outliers relative abundance (dCT) correlated
linearly with the abundance at Passage 2 as indicated by the red regression line. At Passage 10
(Fig. 4b), many orfs were no longer detectable as indicated by increased dCT. At Passage 19
(Fig. 4c), only orfs corresponding to genome positions 584 and 166807 (LMP2A), 147521,
161974 (BALF2), 149133 (BVRF2), 143664 (BXLF1), 133162 (BDLF1), 111336 (BKRF4),
89805,89476 (BLLF2, BLLF1b), 87423, 84523 (BSLF1, BSRF1), 79673 (BaRF1), 72113
(BOLF1), 63798 (BPLF1), 57556 (BFLF1), 9672 (BCRF1) were still detectable, and all others
were not. This is indicated by a horizontal dCT line, which no longer correlates with CTs from
Passage 2. OriP maps to 7,421–9,538, Qp to ~85,000 and EBNA-1 to ~96,000 (Fig. 2c). Hence,
within the resolution of our analysis, these essential latent loci were selectively retained in
HONE-1 clone 13 cells.
To independently confirm this observation, we applied unsupervised cluster analysis to the
data (Fig. 4d). Again we found a dramatic difference between parental HONE-1 and HONE-1
clone 13 cells. The parental cell population lost the entire EBV genome at once, as indicated
by the abrupt color change (yellow to blue) for almost all primers between p8 and p12. By
contrast, HONE-1 clone 13 cells show a gradual loss of signal over time, corroborating the
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pair wise regression analyses (Figs. 4a–4c). Some genes were lost between p2 and p6. Others
(middle section) were lost between p5 and p19. Signal fluctuation in between passages did
occur. However, most of these fluctuations were within the margin of error and were only
overemphasized in this particular representation, which is based on raw data rather than
averages (Figs. 4a–4c). BWRF1, BYRF1 and BLRF3 signals were uniformly positive and
therefore not used for comparison. These results confirm that HONE-1 clone 13 cells behave
differently than the uncloned, parental HONE-1 population. The data suggests that HONE-1
clone 13 cells lose the viral episome by gradual fragmentation, resulting in defective episomes
that retain the essential cis-elements longer than orfs with no known role in episome
maintenance.
HONE-1 clone 13 cells lose the EBV episome through successive deletions and
recombination
To explore further the scenario of accumulative deletion/recombination (Fig. 2b), we tested
the hypothesis that adjacent orfs are retained or lost together during passage in culture. To do
so, we established a statistical model based upon the relationship between orf map position
and relative copy number of individual orfs for each passage. Using HONE-1 clone 13 cell
Passages 2, 5, 10 and 19, we calculated the differences in signal (ddCT) between 1 orf and its
immediate neighbor (+1), or its second (+2) and third (+3) adjacent orf as such: ddCT(pi) =
dCT(pi+1) − dCT(pi), ddCT(pi) = dCT(pi+2) − dCT(pi), ddCT(pi) = dCT(pi+3) − dCT(pi). If 2
orfs within a given pair are present, signal difference ddCT(pi) is minimal for cells of the same
passage number. If 1 orf within a given pair is lost then the signal difference ddCT(pi) is
maximal. The further apart 2 orfs are, the more likely it is that a random recombination/deletion
event removes 1 orf, but not the other. This is the principle of gene mapping by recombination
frequency. By contrast, if the entire episome is only lost or maintained as a whole, then the
signal difference ddCT(pi) between any 2 orfs will remain constant regardless of their relative
location on the viral episome.
We computed Z scores of these ddCT(pi), which allowed us to evaluate relative orf retention
at different passages independent of the total copy number. We established pairwise
correlations for all possible combinations (data not shown). Except at Passage 19, where most
of the orf signals were lost, significant overall correlations were evident, as even if individual
orfs are lost by deletion, the majority of orfs remain linked to each other on the episome and
therefore are present at similar levels. However, the further apart (i + 1, 2, 3) any 2 orfs are
located on the EBV episome, the less their relative levels correlate with each other (Fig. 5).
The squared Pearson correlation coefficients comparing Passage 2 (i + 1) standardized ddCTs
to all other passages exemplify this approach (Fig. 5a). For the same input DNA, there exists
a perfect correlation (r2 = 1.00) of all primer pair distances to itself.
The i + 1 distances (immediately adjacent markers) were significantly correlated at Passage 5
(r2 = 0.54) to Passage 2 and Passage 10 (r2 = 0.43) to Passage 2, but not at Passage 19 (r2 =
0.1), since at this point most of the episomes were lost. If viral episomes can only be lost as a
whole, we would expect similar correlation coefficients for more distant markers (i + 2) and
(i + 3) as well. This, however, was not the case.
There was less of a correlation when comparing i + 1 and i + 2 differences at Passage 2 (r2 =
0.27), i.e., for the same DNA than between different Passages 2 and 5 (r2 = 0.54) for immediate
neighbors (i + 1). Even less of a correlation was observed comparing i + 1 to i + 3 differences
(rightmost group). This gradual decrease in correlation would not be expected if the entire
episome were lost at the same time (Model A). This gradual decrease in correlations would
also not be expected for completely random data as shown in Figures 5b–5c. Only a piecemeal
Dittmer et al. Page 8













loss of episomal genetic material is consistent with this result, which proves that more distantly
located orfs are more likely to be separated by recombination or deletion.
The parental cells lost all orf signals at once and thus there were no significant correlations
(data not shown). Hence, the HONE-1 clone 13 phenotype is unlikely to be due to a systematic
bias, but reflects the underlying biological process of episomal loss.
Discussion
Episome maintenance and loss are fundamental to the persistence and oncogenesis of
herpesviruses. Although episomal plasmid maintenance has been studied genetically in detail
in bacteria and lower eukaryotes, (for example, the yeast 2-μm circle30) similar quantitative,
genetic studies in human cells were limited by sensitivity issues before the use of PCR. Through
our new technique of real-time QPCR-based microarrays, here, we are able to provide a detailed
quantitative analysis of EBV episome loss in NPC.
The data presented here provide evidence for 2 consecutive and mechanistically distinct phases
of EBV latent episome loss. As shown previously, the EBV episome is lost rapidly from as
many as 25% of infected cells upon primary infection (reviewed in Ref. 31). It takes 2 to 3
weeks until an episome is stably established in the fraction of cells that can support long-term
maintenance. During this first, “rapid-loss” phase the viral episome or artificial EBV oriP-
dependent episomes are lost in their entirety. Afterward, the episome copy number remains
constant. In EBV positive stable cell lines, the viral episome is replicated in synchrony with
cellular replication and correctly partitioned at cell division in 97% of cells.32 Three percent
of cells even at this second “slow loss” stage lose the episome by a hitherto unspecified
mechanism.27 NPC offers a unique opportunity to study EBV episome loss because NPC-
derived explant cultures lose the virus within 20 passages. In contrast, BL cell lines maintain
EBV much longer, even though Akata and other BL cell lines lose the viral episome over time
and accumulate defective episomes.33,34 With the exception of HONE-1 clone 40 cells and
C666-1 cells,35 no NPC-derived cell line currently exists that stably carries an EBV genome.
9,12 The difference between NPC and BL has been attributed to the fact that BL cells and LCLs
require some EBV transforming functions for growth in culture while NPC do not. This notion
is corroborated by our observation that even though HONE-1 and clone 13 cells lose EBV, the
EBV-negative cells continue to grow in culture (data not shown). Hence, BL and LCL cells,
which lose the virus, die in culture leaving a 100% EBV-positive population to undergo the
next cell division. Human NPC tumors and NPC xenografts retain EBV, presumably, because
EBV is required for growth in vivo,36 but it is unclear whether NPC cells require EBV for
growth in culture.37
A reasonable concern is that we could potentially be observing outgrowth of a contaminating,
EBV negative cell population such as HeLa cells. Such a scenario is inconsistent with our
quantitative analysis (Figs. 4 and 5) showing the selective loss of some EBV genes, while
retaining others (“slow loss phase”). Nevertheless, it is important to provide a history of the
development of the HONE-1 parental, clone 40 and clone 13 cells. In the late 1980s, the Glaser
laboratory (in collaboration with Dr. Kaitai Yao) prepared explant cultures from primary NPC
biopsies. Detailed characterization of 2 such NPC cell lines derived from 2 separate biopsies
(HNE-1 and HONE-1) were published.11–13 A second NPC cell line (C666-1) containing a
stable NPC genome has now been published.35
The HONE-1 parental cell population was established from one of the NPC biopsies and as
uncloned cell populations were undoubtedly heterogenous for cell markers, karyotype and
perhaps for EBV-specific markers as well. As soon as the parental cell culture was established
(Passages 2–3), we went through the process of preparing clone 13 and clone 40 cell lines using
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soft agar cloning. We focused initially on the HONE-1 clone 40 cells because these were EBV
DNA positive and could be induced to produce virus by treating the cells with IUDR. As the
clone 40 cells were being studied, the cells became contaminated with a slow-growing bacteria.
14
Recently, we discovered a small number of uncontaminated frozen stocks of the initial, low-
passage parental explant cultures and another clone, clone 13. These tested positive for EBV
DNA by PCR (Fig. 1), and it is these cells that were used in this study. We have karyotyped
these cells to exclude a possible contamination with other cells (Supplemental Fig. 1). On the
one hand, it is disappointing that clone 13 does not stably maintain the EBV genome. On the
other hand, the reproducible loss of the EBV episome from clone 13 and HONE-1 parental
cultures provided the opportunity to quantitatively analyze episome loss in NPC.
Our biphasic model of EBV episome loss has 1 important limitation. It is population-based,
since we used ~106 cells to derive DNA at each passage. The initial, “rapid loss phase” can be
explained either as synchronous loss of excess episomes from every cell in the population each
carrying the same EBV copy number, or as outgrowth of low episome carrying clones. The
existence of clone 13, which starts out with a lower episome load, suggests that there is indeed
variation in viral episome copy number within the initial NPC explant population. Perhaps one
could even argue that a high EBV episome number is disadvantageous for growth in culture
and hence cells with high episome loads are rapidly selected against. Further studies are needed
to address this issue.
We set out to understand how the EBV episome is lost during the second “slow-loss phase”.
(i) Is the entire episome lost at once as episome-carrying cells are diluted out of the population
and as epigenetic silencing of the viral genome38 accumulates in the absence of selection? Or
(ii) is the episome lost through successive deletion and recombination events until the essential
cis-elements oriP, Qp and EBNA-1 are no longer within the same cell? Of note, as only a
fraction of each population is used to seed the next flask, extremely variant cell clones and
nonreplication competent pieces of EBV DNA are diluted out. Our study supports the second
model by showing that different portions of the EBV episome were lost at different rates. Large
deletions of the EBV episome occur naturally, and can yield stable episomes in BL. This is
evidenced by the B95-8, which has lost ~11 kbp in the LF3 region,39 and the Daudi and P3HR-1
cell lines, which both have lost ~8 kb in the EBNA2 region40 and others.33,41,42 Perhaps a
particular variant virus confers a selective advantage to a particular clone, for instance by
complementing a host gene defect.43,44 Such a mechanism remains to be shown in the case of
NPC and other EBV-associated epithelial cancers. That latent viral infection can confer a
selective growth advantage is no doubt the case for EBV-infected lymphoma cells45 as well
as clones of endothelial cells infected with the related Kaposi’s sarcoma-associated
herpesvirus.46
We found that there exists a tissue-type-specific upper limit of the number episomes within a
cell (Fig. 1). It appears to be lower in NPC than in BL. A similar observation holds true for
Kaposi sarcoma-associated herpes virus (KSHV), where the average episome copy number in
infected endothelial cell cultures is lower than in B lineage primary effusion lymphoma.46,47
Upon initial explantation, most cells lose the entire episome rapidly and at once (Figs. 2 and
3). They are neither competent to maintain the viral episome nor did the EBV episome confer
a selective advantage at this stage. However, in every generation individual clones exist, such
as the HONE clone 13 in our study, which have the ability to maintain viral episomes after
prolonged passage. We found that in these cells a second mechanism was responsible for the
episome loss. Rather than losing all genes at once, successive deletions took place. We
speculate that any viral episome will sustain deleterious mutations at the same rate as the cell’s
chromosome. Mutations that do not affect the essential latent replication and maintenance loci
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accumulate, because, less than 10% of viral genes are expressed during and required for latency.
Only when one of the essential viral episome maintenance loci (EBNA-1, oriP and Qp) are hit
is the entire episome lost. Based upon our array results shown in Figure 4, we propose that
large deletions are rare, but small deletions and subsequent recombination events (size of 1 orf
or smaller) occur more frequently.
EBV contains internal repeats in the BamW region, which may expand and contract during
passage in culture. Our array contained no primers in the IR region, but 1 primer pair (BWRF1),
which was able to anneal at multiple positions within BamW region (Fig. 3). It is therefore
conceivable that contractions within the BamW region may affect calculations that involve this
1 BWRF1 primer pair. It would not affect the other 74 primer pairs or our statistical modeling.
We did not see any anomalies in the CT values for BWRF1.
Using the novel approach presented here, the mechanism of episomal loss and selective marker
retention can be analyzed for other latent, episomal viruses as well, such as for KSHV. Like
EBV from NPC KSHV is lost upon explantation of primary Kaposi sarcoma biopsies in culture,
such that to date not a single tumor-derived cell line exists that carries KSHV.48,49 Yet, similar
to long-term latent EBV persistence in BL, KSHV is indefinitely maintained in suspension
cultures of PEL. Our approach is suitable for automation and high throughput analysis of
clinical samples. It should be useful for the development of approaches to cure latent infection
by accelerating the rate of viral episome loss.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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(a) Ethidium bromide stained 2% agarose gel of the products of real-time QPCR using primers
specific for GAPDH (labeled G) or EBV Lmp-1 (labeled L). The input was DNA from Hone-1
parental cells at Passage 8 (labeled p.8) from duplicate cultures, Passage 12 (labeled p.12) and
Passage 21 (labeled p.21). Molecular weight markers (M) are indicated on the left. (b, c) Shown
on the vertical axis is the relative abundance of EBV DNA (dCT) on a log scale. Higher CT
corresponds to lower abundance. The real-time QPCR result for EBV DNA was normalized
to total DNA to yield the average copy number per cell. The limit of detection was dCT = 25,
which corresponds to less than 1 copy per million cells. The horizontal axis shows the passage
number for either cl.13 or the primary HONE-1 cell explant culture.
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Possible scenarios for EBV episomal loss: (a) Loss of the entire episome at once (all markers)
and (b) progressive loss of nonessential regions (adjacent markers) by successive
recombination events. Any cell that does not retain EBNA1, oriP and Qp loses all EBV genome
DNA at the next cell division. (c) Relative positions of the essential elements for EBV latent
persistence in NPC (Type II).
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Genome coverage with 75 EBV orf-specific primer pairs. Plotted is the number of matches for
a given primer on the vertical axis vs. the position of the primer on the horizontal axis. Primers
used are shown in gray diamonds. Here, the number of matches equals the total primer length.
The next best match for each primer on the EBV genome is shown in open circles. Numbers
indicate approximate map positions in bp.
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(a–c) Plot of log relative levels (dCT(GAPDH)) for HONE-1 clone 13 cells passage 5, 10 and
19 on the vertical and Passage 2 on the horizontal axis. Shown is the mean of biological
duplicates. (d) Tree-view representation of all CT data. Yellow indicates higher and blue lower
levels. We used median-centered CT values without removing outliers as basis for clustering.
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Shown are statistical measures of the correlation in copy number between any 2 adjacent EBV
orf at different passages. (a) Histogram of squared correlation coefficients (and p values) of
the difference in levels (ddCT) between all orfs (as measured by our primer pairs) and their
neighboring orfs. The first group represents the combinations of ddCT(i + 1), i.e., between
each orf and its nearest neighbor, at Passage 2 to all later passages (p6, p10, p19). The second
group represents the correlations at Passage 2 to all later passages (p6, p10, p19) for the i + 2
neighbors and the third group for the i + 3 neighbors. More distant orfs are less correlated than
adjacent orfs and levels for later passages are less correlated Passage 2 than earlier passages.
Consistent with successive small deletions. (b) Shown is the observed distribution of relative
differences between any 2 immediately adjacent orfs at passage p2, which is compared to a
distribution (c) of random pairs of orfs (using 1,000 random combinations of the CT values).
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